Evaluation of excess significance bias in animal studies of neurological diseases
- PMID: 23874156
- PMCID: PMC3712913
- DOI: 10.1371/journal.pbio.1001609
Evaluation of excess significance bias in animal studies of neurological diseases
Abstract
Animal studies generate valuable hypotheses that lead to the conduct of preventive or therapeutic clinical trials. We assessed whether there is evidence for excess statistical significance in results of animal studies on neurological disorders, suggesting biases. We used data from meta-analyses of interventions deposited in Collaborative Approach to Meta-Analysis and Review of Animal Data in Experimental Studies (CAMARADES). The number of observed studies with statistically significant results (O) was compared with the expected number (E), based on the statistical power of each study under different assumptions for the plausible effect size. We assessed 4,445 datasets synthesized in 160 meta-analyses on Alzheimer disease (n = 2), experimental autoimmune encephalomyelitis (n = 34), focal ischemia (n = 16), intracerebral hemorrhage (n = 61), Parkinson disease (n = 45), and spinal cord injury (n = 2). 112 meta-analyses (70%) found nominally (p≤0.05) statistically significant summary fixed effects. Assuming the effect size in the most precise study to be a plausible effect, 919 out of 4,445 nominally significant results were expected versus 1,719 observed (p<10⁻⁹). Excess significance was present across all neurological disorders, in all subgroups defined by methodological characteristics, and also according to alternative plausible effects. Asymmetry tests also showed evidence of small-study effects in 74 (46%) meta-analyses. Significantly effective interventions with more than 500 animals, and no hints of bias were seen in eight (5%) meta-analyses. Overall, there are too many animal studies with statistically significant results in the literature of neurological disorders. This observation suggests strong biases, with selective analysis and outcome reporting biases being plausible explanations, and provides novel evidence on how these biases might influence the whole research domain of neurological animal literature.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Comment in
-
The shadow of bias.PLoS Biol. 2013 Jul;11(7):e1001608. doi: 10.1371/journal.pbio.1001608. Epub 2013 Jul 16. PLoS Biol. 2013. PMID: 23874155 Free PMC article. No abstract available.
References
-
- van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, et al. (2010) Can animal models of disease reliably inform human studies? PLoS Med 7: e1000245 doi:10.1371/journal.pmed.1000245 - DOI - PMC - PubMed
-
- O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, et al. (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59: 467–477. - PubMed
-
- Sena E, van der Worp HB, Howells D, Macleod M (2007) How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci 30: 433–439. - PubMed
MeSH terms
Grants and funding
- G1002605/MRC_/Medical Research Council/United Kingdom
- G108/613/MRC_/Medical Research Council/United Kingdom
- NC/K000659/1/NC3RS_/National Centre for the Replacement, Refinement and Reduction of Animals in Research/United Kingdom
- NC/L000970/1/NC3RS_/National Centre for the Replacement, Refinement and Reduction of Animals in Research/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
